Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 24, 2005

View Archived Issues

New data on the pharmacokinetics of 667-Coumate in rats

Enrollment completed in phase II PAOD trial of NCX-4016

Sention to develop mGluR antagonists for Fragile X mental retardation

Jerini and Alcon collaborate on novel ophthalmology drugs

Novartis grants Meda European rights to Cibacen and Cibadrex

Novartis: pipeline review

Novel TRPV1 antagonist effective in animal model of inflammatory pain

Efficacy of R-135853 in mouse candidiasis

Researchers at Leiden University synthesize a novel ENT1 inhibitor

Rigel and Pfizer sign collaborative and license agreement for respiratory diseases

GenVec signs malaria vaccine contract with Department of Defense

Phase I study investigates pralatrexate in NSCLC

Copernicus receives award to advance genetic therapy for cystic fibrosis

Pegasys receives positive opinion in E.U. for hepatitis B

Antiinflammatory compounds described in a patent

Scientists at Pfizer claim beta2-adrenoceptor agonists for respiratory diseases

Novel gamma-secretase inhibitors for the treatment of Alzheimer's disease reported by Roche

Agents for the treatment of estrogen-dependent diseases described in a patent

New anticoagulant agents from Bayer

Several GSK and Pliva patents cover antibacterial agents

Depression reported to reduce the efficacy of IFN-alpha plus ribavirin in hepatitis C

Zolmitriptan nasal spray provides effective total pain relief in migraine patients

Improved gastrointestinal recovery found with MNTX after abdominal surgery

Update on the efficacy and safety of viramidine in chronic hepatitis C

Good safety profile found for PYM-50028 in AD patients

VRPs expressing HER2/neu prevent breast cancer growth and tumorigenesis in mice

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...